These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

960 related items for PubMed ID: 24989020

  • 1. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S, McIntosh J, Shealy KM, Borgelt LM, Forinash A, Shrader SP, Koepf ER, McClendon KS, Griffin BL, Horlen C, Karaoui LR, Rowe EL, Lodise NM, Wigle PR.
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [Abstract] [Full Text] [Related]

  • 2. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG, Barar R, Gould H, Gomez I, Nguyen D, Biggs MA.
    Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
    [Abstract] [Full Text] [Related]

  • 3. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT, Anderson BL, Power ML, Raglan GB, Espey E, Schulkin J.
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [Abstract] [Full Text] [Related]

  • 4. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
    Morse J, Freedman L, Speidel JJ, Thompson KM, Stratton L, Harper CC.
    Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
    [Abstract] [Full Text] [Related]

  • 5. Long-acting reversible contraception: a practical solution to reduce unintended pregnancy.
    Secura G.
    Minerva Ginecol; 2013 Jun; 65(3):271-7. PubMed ID: 23689169
    [Abstract] [Full Text] [Related]

  • 6. Long-Acting Reversible Contraception: An Essential Guide for Pediatric Primary Care Providers.
    Allen S, Barlow E.
    Pediatr Clin North Am; 2017 Apr; 64(2):359-369. PubMed ID: 28292451
    [Abstract] [Full Text] [Related]

  • 7. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Mazza D, Bateson D, Frearson M, Goldstone P, Kovacs G, Baber R.
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
    [Abstract] [Full Text] [Related]

  • 8. A qualitative analysis of long-acting reversible contraception.
    Sundstrom B, Baker-Whitcomb A, DeMaria AL.
    Matern Child Health J; 2015 Jul; 19(7):1507-14. PubMed ID: 25424456
    [Abstract] [Full Text] [Related]

  • 9. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
    Dodson NA, Gray SH, Burke PJ.
    Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
    [Abstract] [Full Text] [Related]

  • 10. Current challenges in contraception in adolescents and young women.
    Cornet A.
    Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
    [Abstract] [Full Text] [Related]

  • 11. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I, LARC Guideline Development Group.
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [Abstract] [Full Text] [Related]

  • 12. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M, Torres L, Vollett-Krech J, Wohltjen H.
    Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
    [Abstract] [Full Text] [Related]

  • 13. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP, Roberts TA, Klein DA.
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [Abstract] [Full Text] [Related]

  • 14. Direct pharmacy access to hormonal contraception: California physician and advanced practice clinician views.
    Rafie S, Haycock M, Rafie S, Yen S, Harper CC.
    Contraception; 2012 Dec; 86(6):687-93. PubMed ID: 22717185
    [Abstract] [Full Text] [Related]

  • 15. Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.
    Kavanaugh ML, Jerman J, Ethier K, Moskosky S.
    J Adolesc Health; 2013 Mar; 52(3):284-92. PubMed ID: 23298980
    [Abstract] [Full Text] [Related]

  • 16. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
    Garrett CC, Keogh LA, Kavanagh A, Tomnay J, Hocking JS.
    BMC Womens Health; 2015 Sep 10; 15():72. PubMed ID: 26359250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs).
    Beeson T, Wood S, Bruen B, Goldberg DG, Mead H, Rosenbaum S.
    Contraception; 2014 Feb 10; 89(2):91-6. PubMed ID: 24210278
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Providing long-acting reversible contraception services in Seattle school-based health centers: key themes for facilitating implementation.
    Gilmore K, Hoopes AJ, Cady J, Amies Oelschlager AM, Prager S, Vander Stoep A.
    J Adolesc Health; 2015 Jun 10; 56(6):658-65. PubMed ID: 26003582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.